Guardian Pharmacy Services Inc. (GRDN) reached an all-time high of $47.05 on the U.S. stock market, pushing the company’s valuation to approximately $2.94 billion.
The milestone came after the company reported second-quarter results that exceeded analyst expectations on guidance, triggering a positive reaction from investors. Guardian Pharmacy Services demonstrated continued resilience in the long-term care pharmacy segment, according to the firm’s latest disclosures.
No specific quarterly earnings or revenue figures were provided in the report.
Shares have climbed 54.5% year-to-date through the recent session and are up 72.23% over the trailing twelve months. Despite the strong run, the stock is trading above InvestingPro’s Fair Value estimate, placing it among overvalued names in the healthcare sector per the data provider’s screening criteria.
InvestingPro rates Guardian Pharmacy Services with a "GREAT" financial health score. A Pro Research Report covering GRDN and more than 1,400 U.S. equities is available through the service.
